These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18800457)

  • 1. Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome.
    de Zeeuw D; Gansevoort RT; Dullaart RP; de Jong PE
    J Hypertens Suppl; 1995 Jul; 13(1):S53-8. PubMed ID: 18800457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin.
    Krikken JA; Waanders F; Dallinga-Thie GM; Dikkeschei LD; Vogt L; Navis GJ; Dullaart RP
    Expert Opin Ther Targets; 2009 May; 13(5):497-504. PubMed ID: 19397474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.
    Gansevoort RT; de Zeeuw D; Shahinfar S; Redfield A; de Jong PE
    J Hypertens Suppl; 1994 Jul; 12(2):S37-42. PubMed ID: 7965264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.
    Stenvinkel P; Berglund L; Ericsson S; Alvestrand A; Angelin B; Eriksson M
    Eur J Clin Invest; 1997 Feb; 27(2):169-77. PubMed ID: 9061312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of nephrotic hyperlipoproteinemia with gemfibrozil.
    Groggel GC; Cheung AK; Ellis-Benigni K; Wilson DE
    Kidney Int; 1989 Aug; 36(2):266-71. PubMed ID: 2779095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia.
    Tatò F; Keller C; Wolfram G
    Clin Investig; 1993 Apr; 71(4):314-8. PubMed ID: 8471818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
    Gansevoort RT; Heeg JE; Dikkeschei FD; de Zeeuw D; de Jong PE; Dullaart RP
    Nephrol Dial Transplant; 1994; 9(3):244-50. PubMed ID: 8052429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J; Simó JM; Vilella E; Camps J; Espinel E; Villabona C
    Clin Chem; 1995 Jun; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopheresis in the nephrotic syndrome.
    Brunton C; Varghese Z; Moorhead JF
    Kidney Int Suppl; 1999 Jul; 71():S6-9. PubMed ID: 10412726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion.
    Stenvinkel P; Alvestrand A; Angelin B; Eriksson M
    Eur J Clin Invest; 2000 Oct; 30(10):866-70. PubMed ID: 11029600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome.
    D'Amico G; Gentile MG; Manna G; Fellin G; Ciceri R; Cofano F; Petrini C; Lavarda F; Perolini S; Porrini M
    Lancet; 1992 May; 339(8802):1131-4. PubMed ID: 1349366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
    Deighan CJ; Caslake MJ; McConnell M; Boulton-Jones JM; Packard CJ
    Kidney Int; 2000 Sep; 58(3):1238-46. PubMed ID: 10972686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
    Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
    Vega GL; Ma PT; Cater NB; Filipchuk N; Meguro S; Garcia-Garcia AB; Grundy SM
    Am J Cardiol; 2003 Apr; 91(8):956-60. PubMed ID: 12686335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
    Prata MM; Nogueira AC; Pinto JR; Correia AM; Vicente O; Rodrigues MC; Miguel MJ
    Clin Nephrol; 1994 May; 41(5):277-83. PubMed ID: 8050207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
    Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.